These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38417536)
1. Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation. ; Prabhu M; Louis JM; Kuller JA; Am J Obstet Gynecol; 2024 May; 230(5):B2-B5. PubMed ID: 38417536 [TBL] [Abstract][Full Text] [Related]
2. Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation. Horvath S; Wang L; Calo W; Yazer MH Contraception; 2024 Nov; 139():110530. PubMed ID: 38906503 [TBL] [Abstract][Full Text] [Related]
3. Targeted Rhesus immunoglobulin for RhD-negative women undergoing an induced abortion: A clinical pilot study. Jensen MPS; Damkjaer MB; Clausen FB; Ali HA; Hare KJ; Dziegiel MH; Jørgensen FS Acta Obstet Gynecol Scand; 2019 Sep; 98(9):1164-1171. PubMed ID: 30860294 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study. Slootweg YM; Zwiers C; Koelewijn JM; van der Schoot E; Oepkes D; van Kamp IL; de Haas M BJOG; 2022 Sep; 129(10):1721-1730. PubMed ID: 35133072 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456 [TBL] [Abstract][Full Text] [Related]
6. Rh immunoglobulin utlization after spontaneous and induced abortion. Grimes DA; Ross WC; Hatcher RA Obstet Gynecol; 1977 Sep; 50(3):261-3. PubMed ID: 408768 [TBL] [Abstract][Full Text] [Related]
8. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin? Hannafin B; Lovecchio F; Blackburn P Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810 [TBL] [Abstract][Full Text] [Related]
9. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy. Aitken SL; Tichy EM Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833 [TBL] [Abstract][Full Text] [Related]
11. Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services. Ramsey G; Park YA; Eder AF; Bobr A; Karafin MS; Karp JK; King KE; Pagano MB; Schwartz J; Szczepiorkowski ZM; Souers RJ; Thomas L; Delaney M Arch Pathol Lab Med; 2023 Jan; 147(1):71-78. PubMed ID: 35486492 [TBL] [Abstract][Full Text] [Related]
12. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices. Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065 [TBL] [Abstract][Full Text] [Related]
13. Costs and benefits of non-invasive fetal RhD determination. Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024 [TBL] [Abstract][Full Text] [Related]
14. Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration? Ma KK; Rodriguez MI; Cheng YW; Norton ME; Caughey AB J Matern Fetal Neonatal Med; 2016; 29(11):1866-70. PubMed ID: 26169705 [TBL] [Abstract][Full Text] [Related]
15. Cases of RhD variants RhD*DAU2/DAU6 and RhD*weak D type 4.1 in pregnant women in Saudi Arabia. Owaidah A; Aljuhani K; Albasri J; Alsulmi E; Alsaihati T; Alzahrani F Acta Biomed; 2023 Mar; 94(S1):e2023080. PubMed ID: 36883669 [TBL] [Abstract][Full Text] [Related]
16. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium. Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833 [TBL] [Abstract][Full Text] [Related]
17. [Prevention of Rh D alloimmunization in the first trimester of the pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice]. Vigoureux S; Maurice P; Sibiude J; Garabedian C; Sananès N Gynecol Obstet Fertil Senol; 2024; 52(7-8):446-453. PubMed ID: 38417789 [TBL] [Abstract][Full Text] [Related]
18. Anti-D Alloimmunization in Index Pregnancy after Appropriate Rho(D) Immune Globulin Injection in Two Obese Rh-Negative Patients. Rodriguez S; DeChristopher PJ; Krum K; Lal A AJP Rep; 2024 Jul; 14(3):e228-e230. PubMed ID: 39351243 [No Abstract] [Full Text] [Related]
19. [Guideline for prevention of RhD alloimmunizationin RhD negative women]. Lubušký M; Procházka M; Simetka O; Holusková I Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977 [TBL] [Abstract][Full Text] [Related]